3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
4
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
27
Classical hematology
5
Other
4
Head & Neck
4
Genitourinary
4
Thoracic
3
Endocrine
3
Other hematologic neoplasm
2
Lymphoid
2
Other solid neoplasm
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
9481
Triple Negative Breast Neoplasms
635
Neoplasms
413
Lung Neoplasms
342
Prostatic Neoplasms
321
Ovarian Neoplasms
299
Colorectal Neoplasms
289
Neoplasm Metastasis
280
Motor Activity
267
Carcinoma, Intraductal, Noninfiltrating
231
Colonic Neoplasms
193
Breast Neoplasms, Male
172
Lymphedema
170
Melanoma
158
Pancreatic Neoplasms
152
Breast Carcinoma In Situ
151
Carcinoma, Non-Small-Cell Lung
149
Uterine Cervical Neoplasms
144
Fatigue
140
Head and Neck Neoplasms
132
Pain
122
Breast Cancer Female
122
Brain Neoplasms
118
Stomach Neoplasms
117
Sarcoma
106
Depression
105
Breast Cancer Lymphedema
101
Anxiety Disorders
101
Lymphoma
96
Cardiotoxicity
89
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epilepsy
×
Breast
×
Clear all
NCT02015806
2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA
Completed
53,480 enrolled